Tatevik Ohanyan
Fraunhofer Institute for Translational Medicine and Pharmacology(DE)
Publications by Year
Research Areas
Urticaria and Related Conditions, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Autoimmune Bullous Skin Diseases, Dermatology and Skin Diseases, Mast cells and histamine
Most-Cited Works
- → Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis(2013)272 cited
- → Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria(2016)219 cited
- → Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible Urticaria(2014)153 cited
- → The Urticaria Activity Score—Validity, Reliability, and Responsiveness(2017)138 cited
- → Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab(2018)107 cited
- → Responsiveness and minimal important difference of the urticaria control test(2017)91 cited
- → Comparison and interpretability of the available urticaria activity scores(2017)76 cited
- → Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant(2017)57 cited
- → Real-life treatment of cholinergic urticaria with omalizumab(2018)30 cited
- → Omalizumab may not inhibit mast cell and basophil activation in vitro(2014)18 cited